Cost-effectiveness of solifenacin compared with oral antimuscarinic agents for the treatment of patients with overactive bladder in the UK

Objective: To evaluate the cost-effectiveness of solifenacin 5 mg/day versus other oral antimuscarinic agents used for overactive bladder (OAB) from a UK National Health Service (NHS) perspective. Study design: In a Markov model, hypothetical patients received solifenacin 5 mg/day or a comparator an...

Descripción completa

Detalles Bibliográficos
Autores principales: Hakimi, Zalmai, Kelleher, Con, Aballéa, Samuel, Maman, Khaled, Nazir, Jameel, Mankowski, Colette, Odeyemi, Isaac
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Routledge 2018
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5907635/
https://www.ncbi.nlm.nih.gov/pubmed/29686801
http://dx.doi.org/10.1080/20016689.2018.1438721

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5907635/
https://www.ncbi.nlm.nih.gov/pubmed/29686801
http://dx.doi.org/10.1080/20016689.2018.1438721

Ejemplares similares